ライフサイエンスコーパス: molecular medicine

1 in the fields of molecular cell biology and molecular medicine.

2 res in many areas of chemistry, biology, and molecular medicine.

3 fully realizing the promise of personalized molecular medicine.

4 rder emphasizes the potential and promise of molecular medicine.

5 This is the promise of molecular medicine.

6 implemented as a gene-specific approach for molecular medicine.

7 ngineering as well as disease mechanisms and molecular medicine.

8 m at the interface of chemistry, biology and molecular medicine.

9 innovative platform in chemical biology and molecular medicine.

10 le cell disease was an important landmark in molecular medicine.

11 neration and as vehicles for cell therapy in molecular medicine.

12 ep in fulfilling the promise of personalized molecular medicine.

13 agnostics has the potential to revolutionize molecular medicine.

14 ong the priorities in this emerging field of molecular medicine.

15 have demonstrated considerable potential for molecular medicine.

16 ently being investigated as another tool for molecular medicine.

17 ion of single-base changes is fundamental to molecular medicine.

18 able aptamers and enzymes for exobiology and molecular medicine.

19 prove the delivery and efficacy of nano- and molecular medicines.

20 ression, and treatment in our current era of molecular medicine and individualized patient care.

21 ls, is of relevance in such diverse areas as molecular medicine and materials science.

22 gs are consistent with PML.The Laboratory of Molecular Medicine and Neuroscience (LMMN), National Ins

23 orbent assays performed at the Laboratory of Molecular Medicine and Neuroscience, National Institute

24 t only introduced a new era in the fields of molecular medicine and targeted therapies but may also p

25 icantly enhanced by technical innovations in molecular medicine and the integration of cutaneous biol

26 The merging fields of molecular biology, molecular medicine, and imaging modalities may provide t

27 hese links may be exploited for novel modern molecular medicine approaches.

28 Clinical and molecular medicines are undergoing a revolution based on

29 that this virus is of increasing interest to molecular medicine as a vector for gene delivery, relati

30 and cancer diseases, and for developing new molecular medicine-based therapies.

31 Molecular medicine began with Pauling's seminal work, wh

32 equirement for quantitative data analysis in molecular medicine, biotechnology, microbiology and diag

33 Molecular medicine can benefit greatly from antibodies t

34 ncer biology over the last year have brought molecular medicine closer to the clinic.

35 s promise to accelerate rapidly a new era in molecular medicine, especially in the detection and disc

36 the time is right to implement personalized molecular medicine for all patients with cancer.

37 ly manipulated mammals fulfills a promise of molecular medicine: fusion of molecular biochemistry wit

38 Hypoxia imaging in support of molecular medicine has become an important success story

39 This clinical application of molecular medicine has been based on a growing molecular

40 The ongoing transition from empiric to molecular medicine has engendered a need for correspondi

41 Recent progress in molecular medicine has provided important tools to ident

42 demic programs now embracing the concepts of molecular medicine (i.e., targeting changes in specific

43 nvolve the familiar challenges of delivering molecular medicines in vivo.

44 Here their application in molecular medicine is discussed, especially with regard

45 One important outgrowth of molecular medicine is the development of technologies fo

46 nology that will be driven by the demands of molecular medicine, notably sensitive and specific molec

47 Molecular medicine requires the precise definition of dr

48 ases are increasingly important resources in molecular medicine, systems biology, and pharmacology.

49 ons, as well as lessons for other aspects of molecular medicine, the origin of which can be largely t

50 With advances in molecular medicine, this protein is a segue to a panel o

51 erstanding of gene-nutrient interactions and molecular medicine to address potential mechanisms by wh

52 continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, a

53 fic drug carriers to improve the delivery of molecular medicine to solid tumors.

54 attner (Institute of Infectious Diseases and Molecular Medicine, University of Cape Town).

55 Molecular medicine will require a large number of probes